The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use

Saved in:
Bibliographic Details
Main Authors: Eiermann, Wolfgang (Author) , Rezai, Mahdi (Author) , Kümmel, Sherko (Author)
Other Authors: Kühn, Thorsten (Other) , Warm, Mathias (Other) , Friedrichs, Kay (Other) , Schneeweiss, Andreas (Other) , Markmann, Susanne Christiane (Other) , Eggemann, Holm (Other) , Hilfrich, Jörn (Other) , Jackisch, Christian (Other) , Witzel, Isabell (Other) , Eidtmann, Holger (Other) , Bachinger, A. (Other) , Hell, Susanne (Other) , Blohmer, Jens-Uwe (Other)
Format: Article (Journal)
Language:English
Published: 2013
In: Annals of oncology
Year: 2013, Volume: 24, Issue: 3, Pages: 618-624
ISSN:1569-8041
DOI:10.1093/annonc/mds512
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/annonc/mds512
Verlag, Abstract, Volltext: http://annonc.oxfordjournals.org/content/24/3/618.abstract
Get full text
Author Notes:W. Eiermann, M. Rezai, S. Kümmel, T. Kühn, M. Warm, K. Friedrichs, A. Schneeweiss, S. Markmann, H. Eggemann, J. Hilfrich, C. Jackisch, I. Witzel, H. Eidtmann, A. Bachinger, S. Hell & J. Blohmer
Description
Physical Description:Online Resource
ISSN:1569-8041
DOI:10.1093/annonc/mds512